Healthcare Scan

Scan

Healthcare Scan

Scan symbols 19
ABTAMGNBIIBCVSDXCMGILDISRGJNJLLYMDTMRKMRNAPFESYKTMOUNHVEEVVRTXZTS
Watchlists 1
@healthcare
raw scan snapshot — prices as of scan date, not live 31 rows · screens, not recommendations ported fromresearch/classic/scans/2026-05-29-healthcare-scan.md

EOW tape: ZTS in freefall (RSI 25.4, -32% 30D), ABT/SYK deep in structural downtrends, but LLY/MRK/UNH/CVS all showing recovery; DXCM +24% 30D bounce off lows.

Quick Snapshot

Signal Reading
Overall 🟡 Bifurcated — large managed care (UNH/CVS/MRK) recovering strongly; med devices and specialty pharma in breakdown; ZTS is the sector's biggest casualty
Leaders LLY ($1,105, RSI 69.6, +18% 30D), UNH (+30% 3M, RSI 57.7), CVS (+12.4% 3M, RSI 55.6), MRK (+8.7% 30D)
Laggards ZTS (RSI 25.4, -32% 30D, -55% from ATH), ABT (RSI 38, -25% 3M, -38% from ATH), MDT (RSI 30.5, -24% 3M), SYK (-21% 3M)
Key insight ZTS is the worst stock in healthcare — RSI 25.4, -39% 3M, -55% from ATH. Animal health franchise under severe repricing. ABT also in structural collapse (-38% from ATH).

Price Table

Stock Price RSI vs SMA20 7D% 30D% 3M% 52wkHi% Trend Signal
ZTS $77.69 25.4 ↓ -9.2% -3.29% -32.43% -39.49% -54.89% strong-down 🔍 Research
MDT $73.81 30.5 ↓ -4.3% -3.99% -8.84% -24.15% -30.58% strong-down 🔍 Watch
ABT $85.60 38.0 ↓ -0.8% -2.00% -5.72% -24.52% -38.44% strong-down 🔍 Watch
ISRG $424.64 40.0 -3.1% -3.60% -7.20% -14.43% -29.68% strong-down 🔍 Watch
JNJ $225.33 43.8 -0.5% -1.53% -1.40% -8.82% -10.48% weak-down 🔍 Watch
SYK $305.09 43.5 +0.7% -2.83% -3.19% -20.96% -24.64% strong-down 🔍 Watch
MRNA $47.19 44.2 -2.9% +0.23% +2.72% -10.71% -20.76% weak-down 🔍 Watch
AMGN $336.79 50.6 +1.7% -1.01% -2.00% -12.02% -13.93% weak-down 🔍 Watch
PFE $26.18 52.5 +1.2% +0.81% -0.34% -2.39% -8.94% weak-down 🔍 Watch
GILD $134.43 51.9 +1.2% +2.26% +2.74% -9.89% -14.53% weak-down 🔍 Watch
BIIB $196.00 56.4 +1.5% +1.35% +3.55% +4.23% -4.84% strong-up 🔒 Hold
CVS $90.98 55.6 -0.3% -1.01% +9.23% +12.39% -7.57% strong-up 🔒 Hold
MRK $118.72 56.9 +3.5% -1.63% +8.74% -1.49% -5.13% strong-up 🔒 Hold
UNH $380.31 57.7 -0.6% -1.36% +2.65% +29.95% -5.90% strong-up 🔒 Hold
VRTX $447.54 57.7 +2.6% +2.47% +4.72% -7.92% -11.89% strong-up 🔒 Hold
TMO $492.51 62.3 +7.3% +8.67% +2.83% -3.06% -23.52% weak-up 🔍 Watch
VEEV $174.34 61.7 +6.6% +3.08% +11.78% -3.92% -43.85% weak-up 🔍 Research
DXCM $73.74 69.2 +13.7% +0.31% +23.83% -0.05% -18.05% up ⚠️ Overbought
LLY $1105.00 69.6 +8.8% +5.63% +18.44% +8.74% -3.84% strong-up 🔒 Hold

Tier Analysis

Capitulation (RSI < 30) — Extreme Distress

  • ZTS ($77.69, RSI 25.4) — Zoetis animal health franchise in total collapse. -32.4% 30D, -39.5% 3M, -55% from ATH. Deathcross. This is a structural breakdown, not a cyclical dip. Generic drug competition + GLP-1 weight-loss impact on pet food thesis cracking. Approach with extreme caution — oversold but falling knife.

Oversold (RSI 30–40) — Broken Theses

  • MDT ($73.81, RSI 30.5) — medical devices structural decline. -24% 3M, deathcross. -31% from ATH. Reimbursement pressure + competitive headwinds. No clear catalyst.
  • ABT ($85.60, RSI 38) — Abbott structural breakdown: -38% from ATH, deathcross, -25% 3M. Diagnostic/device franchise losing pricing power.
  • ISRG ($424.64, RSI 40) — surgical robotics pulling back. -14% 3M, -30% from ATH. Deathcross. Quality franchise but repricing vs. older da Vinci installed base.

Neutral (RSI 40–60) — Stable or Mixed

Overbought / Extended (RSI > 60)

  • DXCM (RSI 69.2, +23.8% 30D) — CGM bounce off deep lows. Still -18% from ATH and deathcross active. Mean-reversion trade, not a thesis recovery.
  • LLY (RSI 69.6, +18.4% 30D) — GLP-1 king back near ATH at $1,105. Approaching overbought but momentum intact.
  • VEEV ($174.34, RSI 61.7, +11.8% 30D) — Veeva bouncing off lows. Still -44% from ATH, deathcross. Research needed on turnaround credibility.

Entry Zones

Stock Price Zone RSI 30D% Setup
ZTS $77.69 — 25.4 ↓ -32.43% RSI extreme but falling knife; wait for deceleration in selling before entry.
MDT $73.81 — 30.5 ↓ -8.84% Yield support only. Structural deathcross. Avoid aggressive entry.
ABT $85.60 <$88 38.0 ↓ -5.72% -38% from ATH, deathcross. Diagnostic franchise. Wait for reversal signal.
UNH $380.31 <$390 57.7 +2.65% Post-scandal recovery. +30% 3M, golden cross. Managed care turnaround.

Action Matrix

Action Stocks Why
🔒 HOLD LLY, UNH, CVS, MRK, BIIB, VRTX Strong-up trends, golden crosses, thesis intact
🔍 WATCH / RESEARCH ZTS, ABT, ISRG, MDT, JNJ, SYK, MRNA, GILD, AMGN, PFE, TMO, VEEV Structural breakdowns or mixed signals — need catalyst before entry
⚠️ OVERBOUGHT DXCM +24% 30D bounce but deathcross, -18% from ATH — don't chase
❌ DON'T BUY ZTS Structural collapse, deathcross, no catalyst visible; -55% from ATH

What Changed (directional)

  • ZTS collapse new and severe — -32.4% 30D is extraordinary for an $80B franchise. Generic competition for key drugs accelerating; GLP-1/pet-obesity angle possibly disrupting the vet visit thesis.
  • UNH major recovery — +30% 3M after DOJ fraud probe fears peaked. Managed care repricing complete; golden cross confirmed.
  • LLY back near ATH — -14% 3M in April scan was the bottom; +18.4% 30D recovery brings it within -4% of 52wk high.
  • ABT deepening breakdown — was fragile in April; now firmly -38% from ATH. Diagnostic/Abbott Libre category concerns.
  • DXCM bounce — +24% 30D but the -18% from ATH and deathcross cap this as a relief bounce, not a trend reversal.
  • VEEV tentative recovery — +11.8% 30D off deep lows (-44% from ATH). Cloud CRM for life sciences. Verify turnaround before adding.
  • CVS/MRK outperforming — both posting 8-12% 30D gains while the sector struggles. Managed care + vaccine thesis in reflex bid.
10 events
DateTypeEvent
Jun 16 ScanHealthcare Scan Jun 20 ScanHealthcare Scan Jun 25 ScanHealthcare Scan Jun 26 ScanHealthcare Scan Apr 28 ScanHealthcare Scan Apr 26 ScanHealthcare Scan Jul 11 ScanHealthcare Scan Jul 7 ScanHealthcare Scan Jul 17 ScanHealthcare Scan Apr 13 Scan2 — HEALTHCARE SCAN

No direct external sources are attached to this read.